NCT05914792View on ClinicalTrials.gov

Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery

Active, not recruitingOBSERVATIONAL

Enrollment

49

Participants

Timeline

Start Date

April 19, 2022

Primary Completion Date

October 16, 2024

Study Completion Date

July 1, 2026

Conditions

Breast Cancer

Trial Locations (1)

15232

UPMC Magee Womens Hospital - Surgical Oncology, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Natera, Inc.

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT05914792 - Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery | Biotech Hunter | Biotech Hunter